Published in F1000Res on January 16, 2015
Adult venovenous extracorporeal membrane oxygenation for severe respiratory failure: Current status and future perspectives. Ann Card Anaesth (2016) 0.83
Ketamine use in sedation management in patients receiving extracorporeal membrane oxygenation. Intensive Care Med (2016) 0.77
Medicating patients during extracorporeal membrane oxygenation: the evidence is building. Crit Care (2017) 0.75
Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med (2013) 11.44
The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest (1998) 5.98
Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med (2012) 5.15
Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology (2007) 2.83
The reality of drug shortages--the case of the injectable agent propofol. N Engl J Med (2010) 1.84
Ketamine. Handb Exp Pharmacol (2008) 1.72
Postoperative ketamine administration decreases morphine consumption in major abdominal surgery: a prospective, randomized, double-blind, controlled study. Anesth Analg (2008) 1.64
Sedation depth and long-term mortality in mechanically ventilated critically ill adults: a prospective longitudinal multicentre cohort study. Intensive Care Med (2013) 1.56
Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care (2012) 1.41
Ketamine as a novel antidepressant: from synapse to behavior. Clin Pharmacol Ther (2011) 1.34
Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes. Intensive Care Med (2004) 1.32
Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med (2011) 1.27
In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion (2000) 1.26
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation. Crit Care (2012) 1.23
National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med (2004) 1.17
Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet (2010) 1.17
A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety. Crit Care (2010) 1.16
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO. BMC Anesthesiol (2012) 1.07
Neuroprotection by ketamine: a review of the experimental and clinical evidence. J Cardiothorac Vasc Anesth (2009) 0.94
Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure. Anaesth Intensive Care (2012) 0.93
Role of novel drugs in sedation outside the operating room: dexmedetomidine, ketamine and remifentanil. Curr Opin Anaesthesiol (2014) 0.92
Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med (1994) 0.91
The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation. BMC Anesthesiol (2013) 0.88
Top 10 myths regarding sedation and delirium in the ICU. Crit Care Med (2013) 0.87
Continuous intravenous infusion of ketamine for maintenance sedation. Minerva Anestesiol (2011) 0.87
Plasma concentrations of midazolam in neonates receiving extracorporeal membrane oxygenation. ASAIO J (2003) 0.87
Current status of ketamine and related compounds for depression. J Clin Psychiatry (2013) 0.86
Very-low-dose ketamine for the management of pain and sedation in the ICU. J Opioid Manag (2008) 0.82